RECRUITING

Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed 6-month pilot Sequential Multiple Assignment Randomize Trial (SMART) has two aims. The first and primary aim is to determine the feasibility of conducting a full-scale SMART to compare weight-focused (i.e., weight loss) and weight-neutral (i.e., weight loss is not an explicit goal) adaptive biobehavioral interventions for improving cardiometabolic health in Black adults with overweight or obesity (BMI ≥27 kg/m2) plus at least one weight-related cardiometabolic condition (high blood pressure, prediabetes or diabetes, and/or high cholesterol). Biobehavioral interventions are treatment strategies that combine lifestyle-based behavioral interventions such as eating a healthy diet and exercise with medications. In this study, participants will be randomly assigned to receive either weight-focused or weight-neutral health coaching for 7 weeks. At week 8, participants will be identified as either "responders" or "nonresponders" to the initial interventions. The threshold for response in the weight-focused condition is greater than or equal to 3% weight loss. The threshold for response in the weight-neutral condition is engaging in greater than or equal to 150 minutes of moderate physical activity for the 7 days prior to the week 8 study visit. Responders to the initial interventions will continue with health coaching on a biweekly basis for weeks 9-26 of the intervention. Nonresponders will be re-randomized to either intensify the lifestyle-based intervention by receiving a membership to the YMCA and enrolling in group fitness classes or augmenting the health coaching with enhanced medical management in partnership with their established primary care provider. The second aim is to use clinical data from the pilot SMART to estimate treatment effects and the between-person variability in these effects. Because this is a pilot study, these estimates will not be used to make comparisons or draw conclusions on the comparative effectiveness of intervention conditions. Rather, these data will be used to generate preliminary effect sizes that can be used to estimate the sample size required for a full-scale trial. Clinical trial feasibility data will be collected on an ongoing basis throughout the study and clinical data will be collected prior to initiating the intervention (baseline) and at week 8 (response visit) and week 26 (post-intervention visit).

Official Title

Weight-focused Vs. Weight-neutral Adaptive Biobehavioral Strategies for Improving Metabolic Health in Black Adults with Stage 1 Obesity: a Pilot Sequential Multiple Assignment Randomized Trial

Quick Facts

Study Start:2024-10-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06284681

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥18 years
  2. * BMI ≥27 kg/m2 plus a diagnostic history of 1 or more of the following:
  3. * Prehypertension or hypertension
  4. * Prediabetes or type 2 diabetes
  5. * Dyslipidemia
  6. * Has a primary care provider who is willing to participate in enhanced medical management condition as needed
  7. * Access and ability to use a device with reliable internet connectivity
  8. * Able to converse and read English
  9. * Willingness to enroll in any possible intervention conditions
  10. * Willingness to engage in post-intervention focus group
  1. * Presence of any condition precluding engagement in the prescribed diet or exercise interventions
  2. * Currently engaged in a structured lifestyle-based or weight loss intervention

Contacts and Locations

Study Contact

Drew Sayer, PhD
CONTACT
(205) 354-8950
sayerd@uab.edu
Chelsi Reynolds
CONTACT
(205) 600-8023
cnreynolds@uabmc.edu

Principal Investigator

Drew Sayer, PhD
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35294
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Drew Sayer, PhD, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Obesity
  • Prehypertension
  • Hypertension
  • PreDiabetes
  • Type 2 Diabetes
  • Dyslipidemia